Nomogram Model for Prediction of SARS-CoV-2 Breakthrough Infection in Fujian: A Case-Control Real-World Study

被引:2
|
作者
Chen, Tianbin [1 ,2 ]
Zeng, Yongbin [1 ,2 ]
Yang, Di [3 ]
Ye, Wenjing [4 ]
Zhang, Jiawei [1 ,2 ]
Lin, Caorui [1 ,2 ]
Huang, Yihao [3 ]
Ye, Yucheng [1 ,2 ]
Li, Jianwen [3 ]
Ou, Qishui [1 ,2 ]
Li, Jinming [5 ]
Liu, Can [1 ,2 ]
机构
[1] Fujian Med Univ, Gene Diag Res Ctr, Dept Lab Med, Affiliated Hosp 1, Fuzhou, Peoples R China
[2] Fujian Med Univ, Fujian Key Lab Lab Med, Affiliated Hosp 1, Fuzhou, Peoples R China
[3] East China Normal Univ, Software Engn Inst, Shanghai, Peoples R China
[4] Fujian Prov Ctr Dis Control & Prevent, Dept Emergency Response & Epidem Situat Monitoring, Fuzhou, Peoples R China
[5] Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Natl Ctr Clin Labs,Natl Ctr Gerontol, Beijing, Peoples R China
关键词
SARS-CoV-2 breakthrough infection; vaccinated individuals; nomogram; prediction; model;
D O I
10.3389/fcimb.2022.932204
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
SARS-CoV-2 breakthrough infections have been reported because of the reduced efficacy of vaccines against the emerging variants globally. However, an accurate model to predict SARS-CoV-2 breakthrough infection is still lacking. In this retrospective study, 6,189 vaccinated individuals, consisting of SARS-CoV-2 test-positive cases (n = 219) and test-negative controls (n = 5970) during the outbreak of the Delta variant in September 2021 in Xiamen and Putian cities, Fujian province of China, were included. The vaccinated individuals were randomly split into a training (70%) cohort and a validation (30%) cohort. In the training cohort, a visualized nomogram was built based on the stepwise multivariate logistic regression. The area under the curve (AUC) of the nomogram in the training and validation cohorts was 0.819 (95% CI, 0.780-0.858) and 0.838 (95% CI, 0.778-0.897). The calibration curves for the probability of SARS-CoV-2 breakthrough infection showed optimal agreement between prediction by nomogram and actual observation. Decision curves indicated that nomogram conferred high clinical net benefit. In conclusion, a nomogram model for predicting SARS-CoV-2 breakthrough infection based on the real-world setting was successfully constructed, which will be helpful in the management of SARS-CoV-2 breakthrough infection.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study
    De Vito, Andrea
    Poliseno, Mariacristina
    Colpani, Agnese
    Zauli, Beatrice
    Puci, Mariangela Valentina
    Santantonio, Teresa
    Meloni, Maria Chiara
    Fois, Marco
    Fanelli, Chiara
    Saderi, Laura
    Fois, Alessandro
    Fiore, Vito
    Sotgiu, Giovanni
    Babudieri, Sergio
    Lo Caputo, Sergio
    Madeddu, Giordano
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (12) : 2029 - 2033
  • [42] NeuroCOVID protocol and pilot results: a multicentre case-control study of acute stroke and SARS-CoV-2 infection
    Silva, R.
    Ferreira, M.
    Magalhaes, J.
    Lant, S.
    Gasque, K.
    Abuquerque, M.
    Braga, M.
    Morais, C.
    Salvi, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 772 - 772
  • [43] Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study
    Sgherza, Nicola
    Curci, Paola
    Rizzi, Rita
    Strafella, Vanda
    Di Gennaro, Daniela
    Vitucci, Angelantonio
    Palma, Antonio
    Rossi, Antonella Vita Russo
    Albano, Francesco
    Stefanizzi, Pasquale
    Tafuri, Silvio
    Musto, Pellegrino
    [J]. HAEMATOLOGICA, 2022, 107 (02) : 555 - 557
  • [44] The Effect of Isotonic Saline Nasal Lavages in Improving Symptoms in SARS-CoV-2 Infection: A Case-Control Study
    Spinato, Giacomo
    Fabbris, Cristoforo
    Costantini, Giulio
    Conte, Federica
    Scotton, Pier Giorgio
    Cinetto, Francesco
    De Siati, Rosalba
    Matarazzo, Alessandro
    Citterio, Marco
    Contro, Giacomo
    De Filippis, Cosimo
    Agostini, Carlo
    Emanuelli, Enzo
    Boscolo-Rizzo, Paolo
    Frezza, Daniele
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [45] Correlation of SARS-CoV-2 infection severity with ABO blood groups and RhD antigen: a case-control study
    Omer, Nazaneen Akbar
    Al-Bajalan, Sarwer Jamal
    Rahman, Heshu Sulaiman
    Mohammed, Maryam Salih
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (07)
  • [46] Immunohistochemical Evidence of SARS-CoV-2 in the Placenta After Infection During Pregnancy: A Prospective Case-Control Study
    Renz, Patricia
    Radan, Anda-Petronela
    Trippel, Mafalda
    Haesler, Valerie
    Raio, Luigi
    Surbek, Daniel
    [J]. REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 91 - 92
  • [47] Effectiveness of Messenger RNA Vaccines against SARS-CoV-2 Infection in Hemodialysis Patients: A Case-Control Study
    Alkadi, Mohamad M.
    Hamad, Abdullah
    Ghazouani, Hafedh
    Elshirbeny, Mostafa
    Ali, Mohamed Y.
    Ghonimi, Tarek
    Ibrahim, Rania
    Abuhelaiqa, Essa
    Abou-Samra, Abdul Badi
    Al-Malki, Hassan
    Butt, Adeel A.
    [J]. VACCINES, 2023, 11 (01)
  • [48] Cardiac changes in collegiate athletes following SARS-CoV-2 infection and quarantine: a prospective Case-Control study
    Turpin, Vanessa-Rose G.
    Parr, Shannon K.
    Hammond, Stephen T.
    White, Zachary J.
    Tickner, Preston J.
    Chisam, Chloe E.
    Goerl, Kyle V.
    Drezner, Jonathan A.
    Ade, Carl J.
    [J]. ANNALS OF MEDICINE, 2023, 55 (02)
  • [49] Neonatal outcomes related to maternal SARS-CoV-2 infection in French Guiana: A case-control study.
    Elenga, N.
    Wandji, M. -j.
    Siban, J.
    Nacher, M.
    Demar, M.
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (07) : 746 - 751
  • [50] Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: A case-control study
    Conte, William L.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52